Description

Book Synopsis
Lung cancer has long been the number-one cause of death from cancer every year and the third most frequently diagnosed after breast and prostate cancers. This book provides the research in the identification of biomarkers to predict a high risk for developing lung cancer.

Trade Review

“With almost half of the revised and updated content being brand new, Lung Cancer, Fourth Edition, is an important and vital resource for all medical professionals and students involved in the care and treatment of those struck with this catastrophic illness.” (Kingbook73's Medical Ebook and Video Collection, 19 September 2014)



Table of Contents

Contributors, viii

Preface, xiii

1 Smoking Prevention and Cessation, 1
Alexander V. Prokhorov and Karen Suchanek Hudmon

2 Lung Cancer Susceptibility and Risk Assessment Models, 25
Xifeng Wu, Xia Pu, and Jie Lin

3 Molecular Profiling, 48
Lauren Averett Byers

4 Somatic Genome Alterations in Human Lung Cancers, 67
Marcin Imielinski, Peter S. Hammerman, Roman Thomas, and Matthew Meyerson

5 Serum Proteomic Biomarkers, 90
Mohamed Hassanein and David P. Carbone

6 Molecular Biology of Lung Preneoplasia, 110
Humam Kadara and Ignacio I. Wistuba

7 Detection and Treatment of Preneoplastic Lesions, 129
Rachel Jen and Stephen Lam

8 Pathology of Adenocarcinoma, 144
William D. Travis

9 Management of Multifocal Bronchioloalveolar Carcinoma (BAC), 158
Howard West

10 Radiology and Lung Cancer Screening, 176
Patricia de Groot and Reginald F. Munden

11 Imaging Lung Cancer, 191
Sonia L. Betancourt Cuellar, Edith M. Marom, and Jeremy J. Erasmus

12 Staging of the Mediastinum, 202
Mauricio Pipkin and Shaf Keshavjee

13 Management of the Solitary Pulmonary Nodule, 214
Min P. Kim

14 Minimally Invasive Resections for Lung Cancer, 224
Shanda H. Blackmon

15 Extended Resections for Lung Cancer, 236
Matthew A. Steliga and David C. Rice

16 Bronchoscopic Interventions for Lung Cancer, 253
Donald R. Lazarus and George A. Eapen

17 Primary Tracheal Tumors, 267
Francesco Sammartino and Paolo Macchiarini

18 Adjuvant Chemotherapy Following Surgery for Lung Cancer, 278
Kathryn A. Gold

19 Neoadjuvant Chemotherapy for Resectable Non-Small Cell Lung Cancer, 290
Christopher G. Azzoli and Katherine M.W. Pisters

20 Image-Guided Radiation Therapy, 309
Kenneth E. Rosenzweig and Sonal Sura

21 Stereotactic Ablative Radiotherapy for Lung Cancer, 320
Puneeth Iyengar and Robert D. Timmerman

22 Proton Therapy, 338
Joe Y. Chang and James D. Cox

23 Combinations of Radiation Therapy and Chemotherapy for Non-small Cell and Small-Cell Lung Carcinoma, 353
Daniel Gomez, Zhongxing Liao, Pierre Saintigny, and Ritsuko U. Komaki

24 Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non-small Cell Lung Cancer, 379
Heath D. Skinner, Ritsuko U. Komaki, Joe Y. Chang, and James D. Cox

25 Molecular Target Treatment for Personalized Radiotherapy in Lung Cancer, 390
Steven H. Lin and Ritsuko U. Komaki

26 EGFR Tyrosine Kinase Inhibitors and Monoclonal Antibodies: Clinical Trial Review, 406
Kathryn F. Mileham, Edward S. Kim, and William N. William Jr

27 Mechanisms of Resistance to Epidermal Growth Factor Receptor (EGFR) in Non-small Cell Lung Cancer, 421
Erminia Massarelli

28 Predictive Tumor Biomarkers for EGFR Inhibitors, 435
Lucia Kim, Geoffrey Liu, and Ming-Sound Tsao

29 Immunologic Approaches to Lung Cancer Therapy, 454
Jay M. Lee, Steven M. Dubinett, and Sherven Sharma

30 Novel and Emerging Agents in NSCLC, 464
Anne S. Tsao and Jack A. Roth

31 Novel Clinical Trial Designs for Metastatic Lung Cancer, 479
Vassiliki A. Papadimitrakopoulou

32 Novel Statistical Models for NSCLC Clinical Trials, 488
J. Jack Lee and Caleb T. Chu

33 Tumor Microenvironment, Angiogenesis Biology, and Targeted Therapy, 505
John V. Heymach and Tina Cascone

34 Anti-angiogenic Agents in Metastatic NSCLC, 527
Millie Das and Heather Wakelee

35 Targeting ALK Rearrangements, 541
Justin F. Gainor and Alice T. Shaw

36 Non-small Cell Lung Cancers (NSCLC) with Mutations in BRAF, 557
Renata Ferrarotto and George R. Simon

37 Prognostic and Predictive Biomarker Signatures, 564
Johannes R. Kratz and David M. Jablons

38 Brain Metastasis from Lung Cancer, 572
Ritsuko U. Komaki and Amol J. Ghia

Index, 591

Color plate section between pages 146 and 147

Lung Cancer

    Product form

    £145.76

    Includes FREE delivery

    RRP £161.95 – you save £16.19 (9%)

    Order before 4pm today for delivery by Sat 4 Jul 2026.

    A Hardback by Jack A. Roth, Waun Ki Hong, Ritsuko U. Komaki

    15 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Lung Cancer by Jack A. Roth

      Publisher: John Wiley and Sons Ltd
      Publication Date: 23/05/2014
      ISBN13: 9781118468746, 978-1118468746
      ISBN10: 1118468740
      Also in:
      Oncology

      Description

      Book Synopsis
      Lung cancer has long been the number-one cause of death from cancer every year and the third most frequently diagnosed after breast and prostate cancers. This book provides the research in the identification of biomarkers to predict a high risk for developing lung cancer.

      Trade Review

      “With almost half of the revised and updated content being brand new, Lung Cancer, Fourth Edition, is an important and vital resource for all medical professionals and students involved in the care and treatment of those struck with this catastrophic illness.” (Kingbook73's Medical Ebook and Video Collection, 19 September 2014)



      Table of Contents

      Contributors, viii

      Preface, xiii

      1 Smoking Prevention and Cessation, 1
      Alexander V. Prokhorov and Karen Suchanek Hudmon

      2 Lung Cancer Susceptibility and Risk Assessment Models, 25
      Xifeng Wu, Xia Pu, and Jie Lin

      3 Molecular Profiling, 48
      Lauren Averett Byers

      4 Somatic Genome Alterations in Human Lung Cancers, 67
      Marcin Imielinski, Peter S. Hammerman, Roman Thomas, and Matthew Meyerson

      5 Serum Proteomic Biomarkers, 90
      Mohamed Hassanein and David P. Carbone

      6 Molecular Biology of Lung Preneoplasia, 110
      Humam Kadara and Ignacio I. Wistuba

      7 Detection and Treatment of Preneoplastic Lesions, 129
      Rachel Jen and Stephen Lam

      8 Pathology of Adenocarcinoma, 144
      William D. Travis

      9 Management of Multifocal Bronchioloalveolar Carcinoma (BAC), 158
      Howard West

      10 Radiology and Lung Cancer Screening, 176
      Patricia de Groot and Reginald F. Munden

      11 Imaging Lung Cancer, 191
      Sonia L. Betancourt Cuellar, Edith M. Marom, and Jeremy J. Erasmus

      12 Staging of the Mediastinum, 202
      Mauricio Pipkin and Shaf Keshavjee

      13 Management of the Solitary Pulmonary Nodule, 214
      Min P. Kim

      14 Minimally Invasive Resections for Lung Cancer, 224
      Shanda H. Blackmon

      15 Extended Resections for Lung Cancer, 236
      Matthew A. Steliga and David C. Rice

      16 Bronchoscopic Interventions for Lung Cancer, 253
      Donald R. Lazarus and George A. Eapen

      17 Primary Tracheal Tumors, 267
      Francesco Sammartino and Paolo Macchiarini

      18 Adjuvant Chemotherapy Following Surgery for Lung Cancer, 278
      Kathryn A. Gold

      19 Neoadjuvant Chemotherapy for Resectable Non-Small Cell Lung Cancer, 290
      Christopher G. Azzoli and Katherine M.W. Pisters

      20 Image-Guided Radiation Therapy, 309
      Kenneth E. Rosenzweig and Sonal Sura

      21 Stereotactic Ablative Radiotherapy for Lung Cancer, 320
      Puneeth Iyengar and Robert D. Timmerman

      22 Proton Therapy, 338
      Joe Y. Chang and James D. Cox

      23 Combinations of Radiation Therapy and Chemotherapy for Non-small Cell and Small-Cell Lung Carcinoma, 353
      Daniel Gomez, Zhongxing Liao, Pierre Saintigny, and Ritsuko U. Komaki

      24 Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non-small Cell Lung Cancer, 379
      Heath D. Skinner, Ritsuko U. Komaki, Joe Y. Chang, and James D. Cox

      25 Molecular Target Treatment for Personalized Radiotherapy in Lung Cancer, 390
      Steven H. Lin and Ritsuko U. Komaki

      26 EGFR Tyrosine Kinase Inhibitors and Monoclonal Antibodies: Clinical Trial Review, 406
      Kathryn F. Mileham, Edward S. Kim, and William N. William Jr

      27 Mechanisms of Resistance to Epidermal Growth Factor Receptor (EGFR) in Non-small Cell Lung Cancer, 421
      Erminia Massarelli

      28 Predictive Tumor Biomarkers for EGFR Inhibitors, 435
      Lucia Kim, Geoffrey Liu, and Ming-Sound Tsao

      29 Immunologic Approaches to Lung Cancer Therapy, 454
      Jay M. Lee, Steven M. Dubinett, and Sherven Sharma

      30 Novel and Emerging Agents in NSCLC, 464
      Anne S. Tsao and Jack A. Roth

      31 Novel Clinical Trial Designs for Metastatic Lung Cancer, 479
      Vassiliki A. Papadimitrakopoulou

      32 Novel Statistical Models for NSCLC Clinical Trials, 488
      J. Jack Lee and Caleb T. Chu

      33 Tumor Microenvironment, Angiogenesis Biology, and Targeted Therapy, 505
      John V. Heymach and Tina Cascone

      34 Anti-angiogenic Agents in Metastatic NSCLC, 527
      Millie Das and Heather Wakelee

      35 Targeting ALK Rearrangements, 541
      Justin F. Gainor and Alice T. Shaw

      36 Non-small Cell Lung Cancers (NSCLC) with Mutations in BRAF, 557
      Renata Ferrarotto and George R. Simon

      37 Prognostic and Predictive Biomarker Signatures, 564
      Johannes R. Kratz and David M. Jablons

      38 Brain Metastasis from Lung Cancer, 572
      Ritsuko U. Komaki and Amol J. Ghia

      Index, 591

      Color plate section between pages 146 and 147

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account